Jesse Chen Sells 8,083 Shares of AXT (NASDAQ:AXTI) Stock

AXT Inc (NASDAQ:AXTI) Director Jesse Chen sold 8,083 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $50.25, for a total transaction of $406,170.75. Following the sale, the director directly owned 109,526 shares in the company, valued at approximately $5,503,681.50. The trade was a 6.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Jesse Chen also recently made the following trade(s):

• On Thursday, March 12th, Jesse Chen sold 6,003 shares of AXT stock. The stock was sold at an average price of $48.95, for a total value of $293,846.85.
• On Wednesday, March 11th, Jesse Chen sold 15,000 shares of AXT stock. The shares were sold at an average price of $47.13, for a total value of $706,950.00.
• On Tuesday, March 10th, Jesse Chen sold 14,000 shares of AXT stock. The shares were sold at an average price of $46.15, for a total value of $646,100.00.
• On Monday, March 9th, Jesse Chen sold 12,452 shares of AXT stock. The stock was sold at an average price of $37.69, for a total value of $469,315.88.
• On Friday, March 6th, Jesse Chen sold 2,000 shares of AXT stock. The shares were sold at an average price of $36.63, for a total transaction of $73,260.00.
• On Thursday, March 5th, Jesse Chen sold 11,147 shares of AXT stock. The shares were sold at an average price of $38.26, for a total value of $426,484.22.
• On Wednesday, March 4th, Jesse Chen sold 8,800 shares of AXT stock. The shares were sold at an average price of $38.83, for a total transaction of $341,704.00.
• On Tuesday, March 3rd, Jesse Chen sold 11,007 shares of AXT stock. The stock was sold at an average price of $40.49, for a total value of $445,673.43.
• On Monday, March 2nd, Jesse Chen sold 11,320 shares of AXT stock. The shares were sold at an average price of $45.59, for a total transaction of $516,078.80.

AXT Price Performance

NASDAQ AXTI opened at $44.36 on Wednesday. The company has a market capitalization of $2.45 billion, a P/E ratio of -92.41 and a beta of 1.75. AXT Inc has a 1-year low of $1.13 and a 1-year high of $52.70. The business has a 50 day moving average price of $28.49 and a 200 day moving average price of $15.66.

AXT (NASDAQ:AXTI) last issued its quarterly earnings data on Thursday, February 19th. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.01). The company had revenue of $23.04 million for the quarter, compared to analyst estimates of $24.24 million. AXT had a negative return on equity of 10.59% and a negative net margin of 24.07%. On average, research analysts expect that AXT Inc will post -0.12 earnings per share for the current fiscal year.

Institutional Trading of AXT

A number of hedge funds have recently bought and sold shares of the company. XTX Topco Ltd purchased a new position in shares of AXT in the second quarter worth approximately $42,000. Jefferies Financial Group Inc. purchased a new stake in shares of AXT in the 3rd quarter valued at approximately $52,000. State of Wyoming acquired a new position in AXT in the 4th quarter worth approximately $69,000. Creative Planning acquired a new position in AXT in the 2nd quarter worth approximately $86,000. Finally, Kestra Advisory Services LLC purchased a new position in AXT during the 4th quarter worth approximately $98,000. 49.52% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about AXT

Here are the key news stories impacting AXT this week:

• Positive Sentiment: Large institutional / hedge-fund buying reported in Q4 (e.g., Davidson Kempner, Point72 and others increased or initiated sizable positions), which provides demand support and validates some investor interest in AXT’s market opportunity. QuiverQuant Q4 2025 Earnings & Activity
• Positive Sentiment: Q4 2025 showed improvement in gross profit and a materially larger cash balance (cash & equivalents rose sharply year-over-year), which strengthens the balance sheet runway despite near-term losses. QuiverQuant Q4 2025 Earnings
• Neutral Sentiment: Wall Street views are mixed — several firms boosted targets (Wedbush $28, UBS $35, B. Riley $21) while others remain cautious; consensus is around a mid‑$20s/low‑$20s range, so analyst coverage is supporting but varied. MarketBeat Analyst Summary
• Neutral Sentiment: Reported short interest data shows effectively zero shares outstanding as shorted (days-to-cover ~0.0), which suggests short activity is not a driver of today’s move (the number appears anomalous).
• Negative Sentiment: Heavy insider selling: multiple recent Form 4 filings show substantial sales by the CEO, CFO and directors across early–mid March — large insider disposals can sour sentiment and trigger profit-taking. CEO SEC Filing Director Sale Report
• Negative Sentiment: Operational results remain mixed: revenue declined year-over-year, operating and net losses widened, and operating cash flow fell sharply — these fundamentals keep near-term profitability uncertainty high. QuiverQuant Q4 2025 Earnings
• Negative Sentiment: Market commentary indicates a volatility-driven pullback after a recent sharp rally — profit-taking and reassessment of valuation after the run-up plus the visible insider sales likely accelerated the decline. QuiverQuant Market Note

Wall Street Analyst Weigh In

AXTI has been the subject of a number of recent analyst reports. Wall Street Zen upgraded AXT from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. Wedbush lifted their price target on AXT from $8.50 to $28.00 and gave the stock an “outperform” rating in a research note on Friday, February 20th. UBS Group set a $35.00 target price on shares of AXT in a research note on Tuesday, February 17th. B. Riley Financial upped their target price on AXT to $21.00 and gave the company a “neutral” rating in a report on Friday, February 20th. Finally, Needham & Company LLC lowered shares of AXT from a “buy” rating to a “hold” rating in a research report on Tuesday, January 20th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, AXT has a consensus rating of “Hold” and an average target price of $22.80.

AXT Company Profile

AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.

AXT’s product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.